Stimulation of Fas (CD95) induces production of pro-inflammatory mediators through ERK/JNK-dependent activation of NF-κB in THP-1 cells

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 157-162

  Lee, Sang Min ^a   Kim, Eun Ju ^a   Suk, Kyoungho ^b   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Fas; Inflammation; Macrophage; Signal transduction; TNFSF

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROPHAGE FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; BLOTTING, WESTERN; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 80052351380     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.019     Document Type: Article

References (45)

1. Nagata S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 1999, 33:29-55.
2. Perl M., Chung C.S., Perl U., Lomas-Neira J., de Paepe M., Cioffi W.G., Ayala A. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury,. Am. J. Respir. Crit. Care Med. 2007, 176:591-601.
3. Everett H., McFadden G. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 1999, 7:160-165.
4. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
5. Los M., Burek C.J., Stroh C., Benedyk K., Hug H., Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov. Today 2003, 8:67-77.
6. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989, 169:1747-1756.
7. Lettau M., Paulsen M., Kabelitz D., Janssen O. FasL expression and reverse signalling. Results Probl. Cell Differ. 2009, 49:49-61.
8. Matute-Bello G., Liles W.C., Steinberg K.P., Kiener P.A., Mongovin S., Chi E.Y., Jonas M., Martin T.R. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 1999, 163:2217-2225.
9. Jung D.Y., Lee H., Jung B.Y., Ock J., Lee M.S., Lee W.H., Suk K. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol. 2005, 174:6467-6476.
10. Hamann K.J., Dorscheid D.R., Ko F.D., Conforti A.E., Sperling A.I., Rabe K.F., White S.R. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 1998, 19:537-542.
11. Neff T.A., Guo R.F., Neff S.B., Sarma J.V., Speyer C.L., Gao H., Bernacki K.D., Huber-Lang M., McGuire S., Hoesel L.M., Riedemann N.C., Beck-Schimmer B., Zetoune F.S., Ward P.A. Relationship of acute lung inflammatory injury to Fas/FasL system. Am. J. Pathol. 2005, 166:685-694.
12. de Oliveira G.M., Diniz R.L., Batista W., Batista M.M., Bani Correa C., de Araujo-Jorge T.C., Henriques-Pons A. Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. Am. J. Pathol. 2007, 171:79-86.
13. Altemeier W.A., Zhu X., Berrington W.R., Harlan J.M., Liles W.C. Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent caspase-independent pathway. J. Leukoc. Biol. 2007, 82:721-728.
14. Miwa K., Asano M., Horai R., Iwakura Y., Nagata S., Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 1998, 4:1287-1292.
15. Park D.R., Thomsen A.R., Frevert C.W., Pham U., Skerrett S.J., Kiener P.A., Liles W.C. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 2003, 170:6209-6216.
16. Ma Y., Liu H., Tu-Rapp H., Thiesen H.J., Ibrahim S.M., Cole S.M., Pope R.M. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat. Immunol. 2004, 5:380-387.
17. Freiberg R.A., Spencer D.M., Choate K.A., Duh H.J., Schreiber S.L., Crabtree G.R., Khavari P.A. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol. 1997, 108:215-219.
18. Jelaska A., Korn J.H. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J. Cell. Physiol. 1998, 175:19-29.
19. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F., Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 1993, 178:2231-2235.
20. Alam A., Cohen L.Y., Aouad S., Sekaly R.P. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 1999, 190:1879-1890.
21. Kennedy N.J., Kataoka T., Tschopp J., Budd R.C. Caspase activation is required for T cell proliferation. J. Exp. Med. 1999, 190:1891-1896.
22. Miossec C., Dutilleul V., Fassy F., Diu-Hercend A. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 1997, 272:13459-13462.
23. Wilhelm S., Wagner H., Hacker G. Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur. J. Immunol. 1998, 28:891-900.
24. S.M. Lee, E.J. Kim, K. Suk, W.H. Lee, Stimulation of FasL induces production of pro-inflammatory mediators through activation of mitogen activated protein kinases and nuclear factor-kappaB in THP-1 cells, Inflammation, in press (2011).
25. Bonny C., Oberson A., Negri S., Sauser C., Schorderet D.F. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001, 50:77-82.
26. Lee W.H., Kim S.H., Lee Y., Lee B.B., Kwon B., Song H., Kwon B.S., Park J.E. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler. Thromb. Vasc. Biol. 2001, 21:2004-2010.
27. Kim W.J., Lee W.H. LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Netw. 2004, 4:116-122.
28. Lee S.H., Kim E.J., Suk K., Kim I.S., Lee W.H. TL1A induces the expression of TGF-beta-inducible gene h3 (betaig-h3) through PKC, PI3K, and ERK in THP-1 cells. Cell. Immunol. 2010, 266:61-66.
29. Lee S.M., Jeon S.T., Kim W.J., Suk K., Lee W.H. Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 2010, 131:350-356.
30. Hotokezaka H., Sakai E., Kanaoka K., Saito K., Matsuo K., Kitaura H., Yoshida N., Nakayama K. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J. Biol. Chem. 2002, 277:47366-47372.
31. Planz O., Pleschka S., Ludwig S. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 2001, 75:4871-4877.
32. Birkenkamp K.U., Tuyt L.M., Lummen C., Wierenga A.T., Kruijer W., Vellenga E. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Br. J. Pharmacol. 2000, 131:99-107.
33. Ward S.G., Parry R.V., Matthews J., O'Neill L. A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production. Biochem. Soc. Trans. 1997, 25:304S.
34. Semba S., Itoh N., Ito M., Harada M., Yamakawa M. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002) a specific inhibitor of phosphatidylinositol 3'-kinase In human colon cancer cells. Clin. Cancer Res. 2002, 8:1957-1963.
35. Nauc V., De Lamirande E., Leclerc P., Gagnon C. Inhibitors of phosphoinositide 3-kinase LY294002 and wortmannin affect sperm capacitation and associated phosphorylation of proteins differently: Ca2+ dependent divergences. J. Androl. 2004, 25:573-585.
36. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006, 25:6717-6730.
37. Schmitz M.L., Mattioli I., Buss H., Kracht M. NF-kappaB: a multifaceted transcription factor regulated at several levels. ChemBioChem 2004, 5:1348-1358.
38. Xiao W. Advances in NF-kappaB signaling transduction and transcription. Cell Mol. Immunol. 2004, 1:425-435.
39. Kim W.J., Kang Y.J., Suk K., Park J.E., Kwon B.S., Lee W.H. Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques. Immunol. Invest. 2008, 37:359-373.
40. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase stromelysin and tissue factor. Circulation 1997, 96:396-399.
41. Jeon S.T., Kim W.J., Lee S.M., Lee M.Y., Park S.B., Lee S.H., Kim I.S., Suk K., Choi B.K., Choi E.M., Kwon B.S., Lee W.H. Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol. Cell Biol. 2010, 88:148-156.
42. Lee S.M., Kim W.J., Suk K., Lee W.H. Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages. Immune Netw. 2010, 10:173-180.
43. Bae E.M., Kim W.J., Suk K., Kang Y.M., Park J.E., Kim W.Y., Choi E.M., Choi B.K., Kwon B.S., Lee W.H. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol. Immunol. 2008, 45:523-533.
44. Bae E., Kim W.J., Kang Y.M., Suk K., Koh E.M., Cha H.S., Ahn K.S., Huh T.L., Lee W.H. Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis. Clin. Exp. Immunol. 2007, 148:410-418.
45. Kang Y.J., Kim W.J., Bae H.U., Kim D.I., Park Y.B., Park J.E., Kwon B.S., Lee W.H. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 2005, 29:229-235.